Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hepatitis

Free Subscription 13.10.2025 1 BMC Gastroenterol 1 Dtsch Med Wochenschr 1 Gastroenterol Hepatol 2 Gut 1 Hepatology 1 Int J Cancer 1 J Hepatol 1 J Med Virol 1 J Viral Hepat 2 J Virol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. OUEDRAOGO K, Toure AO, Bocoum FY, Diallo D, et al
   Evaluation of the direct cost of chronic viral hepatitis B in patients monitored at the hepato-gastroenterology department of the Yalgado OUEDRAOGO University Hospital.
   BMC Gastroenterol. 2025;25:717.
   PubMed         Abstract available
   
   

   
   Dtsch Med Wochenschr

2. CORNBERG M, Sandmann L
   [Screening and Prevention of Chronic Viral Hepatitis].
   Dtsch Med Wochenschr. 2025;150:1283-1292.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

3. PASCUAL-DAPENA A, Pocurull A, Forns X
   Severe Acute Hepatitis E with Unilateral Amyotrophic Neuralgia: A Diagnostic Challenge.
   Gastroenterol Hepatol. 2025 Oct 7:502585. doi: 10.1016/j.gastrohep.2025.502585.
   PubMed        
   
   

   
   Gut

4. XU X, Chen J, Yu X, Li Z, et al
   Single-cell analysis identifies RETN(+) monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.
   Gut. 2025 Oct 6:gutjnl-2025-335998. doi: 10.1136/gutjnl-2025-335998.
   PubMed         Abstract available
   
   
5. HUANG R, Trinh HN, Yasuda S, Chau A, et al
   Differential HCC risk among HBV indeterminate types at baseline and by phase transition.
   Gut. 2025;74:1873-1882.
   PubMed         Abstract available
   
   

   
   Hepatology

6. WANG Y, Lu C, Ding L, Lv Q, et al
   To the editor: Clarifying LSM cutoff validation, statistical power, and subgroup applicability in predicting liver-related events in chronic hepatitis B.
   Hepatology. 2025 Oct 7. doi: 10.1097/HEP.0000000000001558.
   PubMed        
   
   

   
   Int J Cancer

7. QIU L, Bai S, Cai J, Fang Y, et al
   Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
   Int J Cancer. 2025 Oct 4. doi: 10.1002/ijc.70186.
   PubMed         Abstract available
   
   

   
   J Hepatol

8. DINKELBORG K, Lhomme S, Gomer A
   Rat Hepatitis E Virus: An Emerging Challenge in Human Hepatitis.
   J Hepatol. 2025 Oct 3:S0168-8278(25)02515-2. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   

   
   J Med Virol

9. YUNIHASTUTI E, Ophinni Y, Sari V, Adli I, et al
   Longitudinal Changes in Immune Biomarkers Following Direct-Acting Antiviral Therapy in HIV/HCV-Coinfected Individuals in Indonesia.
   J Med Virol. 2025;97:e70627.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

10. KOKER G
    Reassessing Cost-Effective Strategies for Hepatitis B Elimination: The Urgent Need for Action-Oriented Screening Models.
    J Viral Hepat. 2025;32:e70084.
    PubMed        
    
    

    
    J Virol

11. MARCOE GJ, Larsen CIS, Summers MF, Majumder K, et al
    Association of hepatitis B virus genomes with active chromatin hubs challenges host replication fidelity, leading to DNA damage.
    J Virol. 2025 Oct 10:e0101425. doi: 10.1128/jvi.01014.
    PubMed         Abstract available
    
    
12. SUN L, Snedeker A, Tang L
    A hepatitis B virus RNA-sensing and RNA-editing-dependent reporter system.
    J Virol. 2025 Oct 10:e0092225. doi: 10.1128/jvi.00922.
    PubMed         Abstract available
    
    

    
    PLoS One

13. LIN CK, Peng YS, Yang CY
    Differences among specialists in using the Electronic Medical Record alert system for HCV screening in outpatients at a large general hospital.
    PLoS One. 2025;20:e0333940.
    PubMed         Abstract available
    
    
14. ERMAN A, Everett K, Wong WWL, Forouzannia F, et al
    Effect of sustained virologic response on liver-related mortality among individuals living with hepatitis C by treatment era: A population-based retrospective cohort study.
    PLoS One. 2025;20:e0333584.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.